Case Reports in Hematology
Volume 2018 (2018), Article ID 7610201, 1 page
https://doi.org/10.1155/2018/7610201

Erratum

Erratum to “A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib”

Daniel S. O’Neil,¹ Mark A. Francescone,² Karen Khan,³ Bachir Alobeid,⁴ Owen A. O’Connor,³ and Ahmed Sawas³

¹Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA
²Department of Radiology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA
³Center for Lymphoid Malignancies, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA
⁴Department of Pathology and Cell Biology, Columbia University Medical Center, College of Physicians and Surgeons, New York, NY, USA

Correspondence should be addressed to Daniel S. O’Neil; dso2116@cumc.columbia.edu

Received 27 September 2018; Accepted 2 October 2018; Published 29 October 2018

Copyright © 2018 Daniel S. O’Neil et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

In the article titled “A Case of Bing–Neel Syndrome Successfully Treated with Ibrutinib” [1], the name format of the fourth author was given incorrectly as Alobeid Bachir. It should have been written as Bachir Alobeid. The corrected author list is shown above.

References

D. S. O’Neil, M. A. Francescone, K. Khan, A. Bachir, O. A. O’Connor, and A. Sawas, “A case of Bing–Neel syndrome successfully treated with ibrutinib,” Case Reports in Hematology, vol. 2018, Article ID 8573105, 5 pages, 2018.